HistoRx Lands $6M in Series B VC Cash to Help Move Its Dx Tools to Market | GenomeWeb
NEW YORK (GenomeWeb News) — HistoRx today said it has raised $6 million in a round of Series B private-equity financing.
The company, based in New Haven, Conn., said it will use the cash to develop and commercialize its tissue-based diagnostics products, which are based on its AQUA biomarker-analysis platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.